Ntm Ab

Ntm Ab company information, Employees & Contact Information

Explore related pages

Related company profiles:

NTM är en stiftelseägd koncern. Genom stiftelseformen garanteras oberoende och stabilitet. Företaget har inga kortsiktiga avkastningskrav så vi kan agera långsiktigt med främsta syfte att bedriva publicistisk verksamhet. NTM är en av Sveriges största koncerner för lokal media. Kärnan i verksamheten är det redaktionella arbetet i våra mediehus, från Småland till Norrbotten. Vi är en stark aktör med nyhetskanaler som når cirka 70 procent av invånarna i våra områden. Våra medierådgivare och reklambyrån Fluid bedriver ett brett kommunikationsarbete och skapar lösningar för det lokala näringslivet att utveckla sin marknadsföring. Flertalet av våra egna tidningar trycks i moderna coldset-anläggningar hos Pressgrannars och Tryck i Norr. Vi trycker även andra publikationer där vi hjälper våra kunder från pre-press till leverans. Vårt eget distributionsbolag Svensk Hemleverans har byggt upp ett starkt distributionsnät genom utdelningen av våra morgontidningar. Det ger oss möjligheten att erbjuda snabba, prisvärda och morgonpigga hemleveranser för både brev och paket i en effektiv och hållbar logistikkedja.

Company Details

Employees
181
Founded
-
Address
Stohagsgatan 2, Norrköping,östergötland 60183,sweden
Industry
Media Production
NAICS
Motion Picture and Video Production
Website
ntm.eu
HQ
Norrköping, Östergötland
Looking for a particular Ntm Ab employee's phone or email?

Ntm Ab Questions

News

Bronchiectasis and NTM Research Registry Data Presented at ERS 2025 - respiratory-therapy.com

Bronchiectasis and NTM Research Registry Data Presented at ERS 2025 respiratory-therapy.com

Insights from the European Nontuberculous mycobacterial pulmonary disease PAtient Disease Experience (ENPADE) survey– exploring disease burden and impact - BMC Pulmonary Medicine

Insights from the European Nontuberculous mycobacterial pulmonary disease PAtient Disease Experience (ENPADE) survey– exploring disease burden and impact BMC Pulmonary Medicine

Nontariff Trade Barriers in the U.S. and EU - Federal Reserve Bank of St. Louis

Nontariff Trade Barriers in the U.S. and EU Federal Reserve Bank of St. Louis

A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom - Nature

A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom Nature

Beyond Air Granted US Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide - respiratory-therapy.com

Beyond Air Granted US Patent Covering Treatment of NTM Infections Using Gaseous Nitric Oxide respiratory-therapy.com

Positive Phase II top-line data highlights omadacycline’s potential in the NTM market - Clinical Trials Arena

Positive Phase II top-line data highlights omadacycline’s potential in the NTM market Clinical Trials Arena

Treatment for non-tuberculous mycobacteria: challenges and prospects - Frontiers

Treatment for non-tuberculous mycobacteria: challenges and prospects Frontiers

Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis - ScienceDirect.com

Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis ScienceDirect.com

IEU-CEPA Trade Agreement Completed After 10 Years of Stallment - Kompas.id

IEU-CEPA Trade Agreement Completed After 10 Years of Stallment Kompas.id

Most Bronchiectasis Patients in Europe Not Tested for NTM Infection as Recommended, Survey Suggests - Bionews

Most Bronchiectasis Patients in Europe Not Tested for NTM Infection as Recommended, Survey Suggests Bionews

Bronchiectasis and NTM 360 Gets a Rebrand - respiratory-therapy.com

Bronchiectasis and NTM 360 Gets a Rebrand respiratory-therapy.com

Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery - BioMed Central

Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery BioMed Central

Bronchiectasis and NTM Establishes Care Center Network with 33 Sites - respiratory-therapy.com

Bronchiectasis and NTM Establishes Care Center Network with 33 Sites respiratory-therapy.com

Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China - BMC Infectious Diseases

Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China BMC Infectious Diseases

FDA Grants Orphan Drug Designation to Antibiotic for NTM Infections - respiratory-therapy.com

FDA Grants Orphan Drug Designation to Antibiotic for NTM Infections respiratory-therapy.com

Anti-malaria Drugs Can Fight NTM Infections - respiratory-therapy.com

Anti-malaria Drugs Can Fight NTM Infections respiratory-therapy.com

High Concentration Inhaled Nitric Oxide Effectively Self-Administered At-home for NTM Lung Disease - respiratory-therapy.com

High Concentration Inhaled Nitric Oxide Effectively Self-Administered At-home for NTM Lung Disease respiratory-therapy.com

New Network Enhances Care for Bronchiectasis and NTM Lung Disease Patients - respiratory-therapy.com

New Network Enhances Care for Bronchiectasis and NTM Lung Disease Patients respiratory-therapy.com

Risk Factors Identified for NTM Lung Infection - respiratory-therapy.com

Risk Factors Identified for NTM Lung Infection respiratory-therapy.com

FDA: NTM Infection Risk with Use of Heater-Cooler Devices - respiratory-therapy.com

FDA: NTM Infection Risk with Use of Heater-Cooler Devices respiratory-therapy.com

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) - Thorax Journal

British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) Thorax Journal

European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Adult Non-CF Patients with Limited Treatment Options - PR Newswire

European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Adult Non-CF Patients with Limited Treatment Options PR Newswire

Arikayce Approved in Europe for MAC Lung Infections in Non-CF Adults - Bionews

Arikayce Approved in Europe for MAC Lung Infections in Non-CF Adults Bionews

Prevalence of Showerhead Bacteria Correlates With Prevalence of NTM Lung Infections - AJMC

Prevalence of Showerhead Bacteria Correlates With Prevalence of NTM Lung Infections AJMC

Introduction to the Amazon SageMaker Neural Topic Model - Amazon Web Services

Introduction to the Amazon SageMaker Neural Topic Model Amazon Web Services

CHMP Recommends Arikayce for MAC Lung Infections in Europe - Bionews

CHMP Recommends Arikayce for MAC Lung Infections in Europe Bionews

Iraq Training Mission Shows NATO’s Future - Atlantic Council

Iraq Training Mission Shows NATO’s Future Atlantic Council

Impact of non-tariff measures to beef & sheep - AHDB

Impact of non-tariff measures to beef & sheep AHDB

Europe | French rappers' prophecies come true - BBC

Europe | French rappers' prophecies come true BBC

Top Ntm Ab Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant